Moreover, ZG16B can also have effect and be a biomarker for early diagnosis and prognosis of prostate cancer [39], oral squamous cell carcinoma [40], and especially ovarian cancer [41,42,43]. Here, ZG16B is linked to ovarian carcinoma.